|
US2444570A
(en)
|
|
1948-07-06 |
|
Drive for counter numeral wheels |
|
GB735443A
(en)
|
1952-09-02 |
1955-08-24 |
English Numbering Machines |
Improvements in or relating to counting devices
|
|
US2828742A
(en)
|
1957-05-02 |
1958-04-01 |
American Home Prod |
Cartridge-needle unit
|
|
NL121491C
(hu)
|
1963-05-02 |
|
|
|
|
US3318289A
(en)
|
1965-05-11 |
1967-05-09 |
Northern Ind Products |
Bi-stable mechanism
|
|
CH499734A
(de)
|
1968-07-19 |
1970-11-30 |
Kienzle Apparate Gmbh |
Klinkengesperre als Einrichtungs- und Überholkupplung
|
|
US3758683A
(en)
|
1971-04-30 |
1973-09-11 |
R Jackson |
Insulin product
|
|
US4282316A
(en)
|
1979-09-11 |
1981-08-04 |
Modrovich Ivan Endre |
Stabilized enzymic solutions for determining urea
|
|
IL62447A
(en)
|
1980-03-21 |
1983-11-30 |
Wellcome Found |
Stabilized ophthalmic formulations
|
|
US4425346A
(en)
|
1980-08-01 |
1984-01-10 |
Smith And Nephew Associated Companies Limited |
Pharmaceutical compositions
|
|
IE52621B1
(en)
|
1981-02-12 |
1988-01-06 |
Turner Robert Charles |
Dose metering plunger devices for use with syringes
|
|
US4568335A
(en)
|
1981-08-28 |
1986-02-04 |
Markwell Medical Institute, Inc. |
Device for the controlled infusion of medications
|
|
DE3204178C2
(de)
|
1982-02-06 |
1986-03-20 |
Eppendorf Gerätebau Netheler + Hinz GmbH, 2000 Hamburg |
Pipettiervorrichtung
|
|
US4483849A
(en)
|
1983-01-07 |
1984-11-20 |
Carter William A |
Stabilization and purification of interferon with propylene glycol, resulting in a non-toxic product
|
|
US4498788A
(en)
|
1983-06-03 |
1985-02-12 |
Diehl Gmbh & Co. |
Escapement for a timer
|
|
DE3468173D1
(en)
|
1983-09-07 |
1988-02-04 |
Disetronic Ag |
Portable infusion apparatus
|
|
US4468346A
(en)
|
1983-10-27 |
1984-08-28 |
The United States Of America As Represented By The Secretary Of Agriculture |
Monoclonal antibodies to porcine immunoglobulins
|
|
JPS60129941U
(ja)
|
1984-02-09 |
1985-08-31 |
テルモ株式会社 |
医療用器具
|
|
US4592745A
(en)
|
1984-02-29 |
1986-06-03 |
Novo Industri A/S |
Dispenser
|
|
FR2583291A1
(fr)
|
1985-06-14 |
1986-12-19 |
Hazon Bernard |
Dispositif d'avancement pas a pas du piston de seringues par double vis coaxiale avec controle du debit d'injection. application aux injections medicamenteuses intra-dermiques repetitives
|
|
DE3546150A1
(de)
|
1985-06-24 |
1987-01-22 |
Hoechst Ag |
Membrananker-wirkstoffkonjugat, seine herstellung sowie seine verwendung
|
|
BR8606965A
(pt)
|
1985-11-08 |
1987-11-03 |
Disetronic Ag |
Aparelho injetor
|
|
DE3609555A1
(de)
|
1986-03-21 |
1987-09-24 |
Josef Porner |
Blutentnahmespritze
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
EP0305387B2
(en)
|
1986-05-05 |
1996-08-28 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US4917685A
(en)
|
1986-05-16 |
1990-04-17 |
International Minerals & Chem. Corp. |
Delivery device for the administration of stabilized growth promoting hormones
|
|
DE3645245C2
(de)
|
1986-11-14 |
1994-01-27 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
|
US5716990A
(en)
|
1987-03-09 |
1998-02-10 |
Cancer Research Campaign Technology Limited |
Drug delivery systems
|
|
DK177187A
(da)
|
1987-04-07 |
1988-10-08 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glasampul
|
|
DE3715258C2
(de)
|
1987-05-08 |
1996-10-31 |
Haselmeier Wilhelm Fa |
Injektionsgerät
|
|
JP2818176B2
(ja)
|
1987-05-14 |
1998-10-30 |
コモンウェルス・サイエンティフィック・アンド・インダストリアル・リサーチ・オーガナイゼーション |
ホエー蛋白フラクション
|
|
GB8713810D0
(en)
|
1987-06-12 |
1987-07-15 |
Hypoguard Uk Ltd |
Measured dose dispensing device
|
|
FI883338A
(fi)
|
1987-07-16 |
1989-01-17 |
Bristol Myers Co |
Vattenloesningar av doxorubicinhydroklorid.
|
|
IT1222331B
(it)
|
1987-08-25 |
1990-09-05 |
Bruno Micovilovich |
Siringa di sicurezza per usi parentali,a disimpegno autonomo e rapido dell'ago dopo l'uso
|
|
US4919596A
(en)
|
1987-12-04 |
1990-04-24 |
Pacesetter Infusion, Ltd. |
Fluid delivery control and monitoring apparatus for a medication infusion system
|
|
US4833379A
(en)
|
1988-01-13 |
1989-05-23 |
Sherwood Medical Company |
Motor control fail-safe circuit
|
|
CH675078A5
(hu)
|
1988-01-22 |
1990-08-31 |
Nosta Ag |
|
|
DE3900926C2
(de)
|
1988-02-08 |
1999-05-12 |
Disetronic Licensing Ag |
Spritzenförmiges Injektionsgerät und Injektionsgerätebaukasten
|
|
US4973318A
(en)
|
1988-02-10 |
1990-11-27 |
D.C.P. Af 1988 A/S |
Disposable syringe
|
|
DK166948B1
(da)
|
1988-02-10 |
1993-08-09 |
Dcp Af 1988 As |
Doseringsenhed til dosering af et antal afmaalte maengder af en vaeske, saasom insulin, fra en glastubule
|
|
WO1990000200A1
(en)
|
1988-06-27 |
1990-01-11 |
Genex Corporation |
Thermal release of recombinant protein into culture media
|
|
EP0359070B1
(de)
|
1988-09-12 |
1995-01-11 |
Grässlin Kg |
Richtgesperre für eine Schaltuhr
|
|
GB8900763D0
(en)
|
1989-01-13 |
1989-03-08 |
Kabi Vitrum Peptide Hormones A |
Multi-dose syringe
|
|
US5216437A
(en)
|
1989-02-02 |
1993-06-01 |
Canon Kabushiki Kaisha |
Ink, and recording method making use of same
|
|
DK68789A
(da)
|
1989-02-14 |
1990-08-15 |
Novo Nordisk As |
Injektionspen
|
|
HU203372B
(en)
|
1989-02-24 |
1991-07-29 |
Richter Gedeon Vegyeszet |
Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
|
|
ATE193541T1
(de)
|
1989-03-20 |
2000-06-15 |
Gen Hospital Corp |
Insulinotropes hormon
|
|
JP2822447B2
(ja)
|
1989-05-19 |
1998-11-11 |
住友電気工業株式会社 |
酸化物超電導線材の製造方法および装置
|
|
US4994033A
(en)
|
1989-05-25 |
1991-02-19 |
Schneider (Usa) Inc. |
Intravascular drug delivery dilatation catheter
|
|
US5226895A
(en)
|
1989-06-05 |
1993-07-13 |
Eli Lilly And Company |
Multiple dose injection pen
|
|
DE3927286C2
(de)
|
1989-08-18 |
1997-07-24 |
Roehm Gmbh |
Wäßrige Enzym-Flüssigformulierungen
|
|
US5216011A
(en)
|
1989-09-01 |
1993-06-01 |
Bristol-Myers Squibb Co. |
Stable solutions of mitomycin c
|
|
DE69013471T2
(de)
|
1989-12-05 |
1995-03-30 |
Merck & Co Inc |
Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
|
|
DK17890A
(da)
|
1990-01-22 |
1991-07-23 |
Novo Nordisk As |
Fremgangsmaade og apparat til opblanding og injicering af et laegemiddel
|
|
EP0512042B1
(en)
|
1990-01-24 |
1998-04-08 |
BUCKLEY, Douglas I. |
Glp-1 analogs useful for diabetes treatment
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
DE4002066A1
(de)
|
1990-01-25 |
1991-08-01 |
Basf Ag |
Verfahren zur abtrennung von riboflavin aus fermentationssuspensionen
|
|
GB9007113D0
(en)
|
1990-03-29 |
1990-05-30 |
Sams Bernard |
Dispensing device
|
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
|
US5318540A
(en)
|
1990-04-02 |
1994-06-07 |
Pharmetrix Corporation |
Controlled release infusion device
|
|
US5492534A
(en)
|
1990-04-02 |
1996-02-20 |
Pharmetrix Corporation |
Controlled release portable pump
|
|
US5226896A
(en)
|
1990-04-04 |
1993-07-13 |
Eli Lilly And Company |
Dose indicating injection pen
|
|
IT220491Z2
(it)
|
1990-04-13 |
1993-09-24 |
Stilolinea Srl |
Penna a sfera del tipo a punta scrivente rientrante
|
|
EP0532546B1
(en)
|
1990-05-10 |
1998-03-18 |
Bechgaard International Research And Development A/S |
A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
|
|
US5257987A
(en)
|
1990-05-21 |
1993-11-02 |
Pharmetrix Corporation |
Controlled release osmotic infusion system
|
|
DK0549694T3
(da)
|
1990-09-21 |
1995-10-16 |
Novo Nordisk As |
Adaptertop
|
|
US5284480A
(en)
|
1990-11-09 |
1994-02-08 |
Medtronic, Inc. |
Inflation/deflation syringe with threaded plunger
|
|
GB9026191D0
(en)
|
1990-12-01 |
1991-01-16 |
Harris Pharma Ltd |
Breath actuated dispensing device
|
|
US5331954A
(en)
|
1990-12-21 |
1994-07-26 |
Novo Nordisk A/S |
Device for nasal delivery of liquid medications
|
|
US5232706A
(en)
|
1990-12-31 |
1993-08-03 |
Esteve Quimica, S.A. |
Oral pharmaceutical preparation containing omeprazol
|
|
AU641206B2
(en)
|
1991-01-22 |
1993-09-16 |
Eli Lilly And Company |
Multiple dose injection pen
|
|
DE69203472T2
(de)
|
1991-02-07 |
1996-01-04 |
Terumo Corp |
Dosiereinrichtung für Injektor.
|
|
US5272135A
(en)
|
1991-03-01 |
1993-12-21 |
Chiron Ophthalmics, Inc. |
Method for the stabilization of methionine-containing polypeptides
|
|
HU222249B1
(hu)
|
1991-03-08 |
2003-05-28 |
Amylin Pharmaceuticals Inc. |
Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
|
|
ATE167229T1
(de)
|
1991-03-27 |
1998-06-15 |
Novo Nordisk As |
Katalase, ihre herstellung und verwendung
|
|
US5258377A
(en)
|
1991-04-08 |
1993-11-02 |
Taiho Pharmaceutical Co., Ltd. |
2-spirocyclopropyl 4-acylcephems
|
|
DE4112259A1
(de)
|
1991-04-15 |
1992-10-22 |
Medico Dev Investment Co |
Injektionsgeraet
|
|
DK68991D0
(da)
|
1991-04-17 |
1991-04-17 |
Novo Nordisk As |
Manifold
|
|
US5645052A
(en)
|
1991-04-26 |
1997-07-08 |
The Boc Group Plc |
Anaesthetic vaporizer with expandable/contractable reservoir for pumping liquid anaesthetic
|
|
SE9101381D0
(sv)
|
1991-05-07 |
1991-05-07 |
Tomas Moks |
Peptide hormone solution
|
|
ATE121953T1
(de)
|
1991-07-24 |
1995-05-15 |
Medico Dev Investment Co |
Injektor.
|
|
DK175491D0
(da)
|
1991-10-18 |
1991-10-18 |
Novo Nordisk As |
Apparat
|
|
US5206219A
(en)
|
1991-11-25 |
1993-04-27 |
Applied Analytical Industries, Inc. |
Oral compositions of proteinaceous medicaments
|
|
EP0614386B1
(en)
|
1991-11-29 |
1996-10-23 |
Novo Nordisk A/S |
A pen-shaped syringe
|
|
DK194291D0
(da)
|
1991-11-29 |
1991-11-29 |
Novo Nordisk As |
Sproejte til automatisk injektion.
|
|
US5246417A
(en)
|
1991-12-11 |
1993-09-21 |
Alza Corporation |
Indicator for iontophoresis system
|
|
US5849700A
(en)
|
1991-12-20 |
1998-12-15 |
Novo Nordisk A/S |
Pharmaceutical formulation
|
|
FR2686460B1
(fr)
|
1992-01-20 |
1994-03-11 |
Labinal Precision Mecanique |
Organe de contact electrique femelle.
|
|
US5279586A
(en)
|
1992-02-04 |
1994-01-18 |
Becton, Dickinson And Company |
Reusable medication delivery pen
|
|
CH682968B5
(fr)
|
1992-02-12 |
1994-06-30 |
Rolex Montres |
Procédé de fabrication d'un joint et joint pour dispositif de commande étanche pour montre obtenu selon ce procédé.
|
|
CH682806A5
(de)
|
1992-02-21 |
1993-11-30 |
Medimpex Ets |
Injektionsgerät.
|
|
DE4208677A1
(de)
|
1992-03-18 |
1993-09-23 |
Injecta Gmbh Steinach |
Injektionsvorrichtung, insbesondere fuer sehgeschaedigte diabetiker
|
|
DK36492D0
(da)
|
1992-03-19 |
1992-03-19 |
Novo Nordisk As |
Praeparat
|
|
WO1993018812A1
(en)
|
1992-03-25 |
1993-09-30 |
Tebro S.A. |
Powder jet dispenser for medicament inhalation therapies
|
|
DK39892D0
(da)
|
1992-03-25 |
1992-03-25 |
Bernard Thorens |
Peptid
|
|
US5271527A
(en)
|
1992-04-02 |
1993-12-21 |
Habley Medical Technology Corporation |
Reusable pharmaceutical dispenser with full stroke indicator
|
|
US5281198A
(en)
|
1992-05-04 |
1994-01-25 |
Habley Medical Technology Corporation |
Pharmaceutical component-mixing delivery assembly
|
|
DK0642332T3
(da)
|
1992-05-13 |
1997-06-16 |
Sandoz Ltd |
Ophthalmiske præparater indeholdende cyclosporin
|
|
EP0646128A1
(en)
|
1992-06-15 |
1995-04-05 |
Scios Inc. |
Glucagon-like peptide and insulinotropin derivatives
|
|
UA26190C2
(uk)
|
1992-07-28 |
1999-07-19 |
Сейфтек Ай Лімітед |
Шприц
|
|
GB9219849D0
(en)
|
1992-09-19 |
1992-10-28 |
Hypoguard Uk Ltd |
Device
|
|
WO1994008647A1
(en)
|
1992-10-15 |
1994-04-28 |
The General Hospital Corporation |
An infusion pump with an electronically loadable drug library
|
|
US5545147A
(en)
|
1992-10-20 |
1996-08-13 |
Eli Lilly And Company |
Anti-backup improvement for hypodermic syringes
|
|
US5378233A
(en)
|
1992-11-18 |
1995-01-03 |
Habley Medical Technology Corporation |
Selected dose pharmaceutical dispenser
|
|
US5320609A
(en)
|
1992-12-07 |
1994-06-14 |
Habley Medical Technology Corporation |
Automatic pharmaceutical dispensing syringe
|
|
GB9226423D0
(en)
|
1992-12-18 |
1993-02-10 |
Sams Bernard |
Incrementing mechanisms
|
|
PL310319A1
(en)
|
1993-02-19 |
1995-12-11 |
Medicorp Holding |
Syringe with integrated receptacle for holding fluid sterile medical substances
|
|
US5383865A
(en)
|
1993-03-15 |
1995-01-24 |
Eli Lilly And Company |
Medication dispensing device
|
|
US5584815A
(en)
|
1993-04-02 |
1996-12-17 |
Eli Lilly And Company |
Multi-cartridge medication injection device
|
|
ZA941881B
(en)
|
1993-04-02 |
1995-09-18 |
Lilly Co Eli |
Manifold medication injection apparatus and method
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
SE9301494D0
(sv)
|
1993-04-30 |
1993-04-30 |
Kabi Pharmacia Ab |
A device for dosing liquid preparation
|
|
DK52393D0
(hu)
|
1993-05-05 |
1993-05-05 |
Novo Nordisk As |
|
|
WO1995005848A1
(en)
|
1993-08-24 |
1995-03-02 |
Novo Nordisk A/S |
Protracted glp-1
|
|
UA45321C2
(uk)
|
1993-09-17 |
2002-04-15 |
Ново Нордіск А/С |
Похідне інсуліну, фармацевтична композиція для лікування діабету та спосіб лікування діабету
|
|
GB9320782D0
(en)
|
1993-10-08 |
1993-12-01 |
Univ Leeds Innovations Ltd |
Stabilising of proteins on solution
|
|
ATE188611T1
(de)
|
1993-11-19 |
2000-01-15 |
Searle & Co |
Transdermale zusammensetzung von n-(n-(5-(4- (aminoiminomethyl)phenyl-1-oxopentyl)-l-alpha- aspartyl)-l-phenylalanin oder deren esterderivaten und ihre pharmazeutischverwendbaren salze
|
|
US5705483A
(en)
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5478316A
(en)
|
1994-02-02 |
1995-12-26 |
Becton, Dickinson And Company |
Automatic self-injection device
|
|
US5562623A
(en)
|
1994-02-14 |
1996-10-08 |
Univec |
Single-use syringe assembly including spring clip lock and plunger
|
|
US5514097A
(en)
|
1994-02-14 |
1996-05-07 |
Genentech, Inc. |
Self administered injection pen apparatus and method
|
|
WO1995022560A1
(en)
|
1994-02-22 |
1995-08-24 |
The Syntex-Synergen Neuroscience Joint Venture |
Pharmaceutical formulations of cntf
|
|
US5741688A
(en)
|
1994-05-03 |
1998-04-21 |
Novo Nordisk A/S |
Alkaline glucose oxidase obtained from cladosporium oxysporum
|
|
GB9409496D0
(en)
|
1994-05-12 |
1994-06-29 |
London Health Ass |
Method for improving glycaemic control in diabetes
|
|
US5750140A
(en)
|
1994-05-20 |
1998-05-12 |
Novo Nordisk A/S |
Transdermal delivery of tiagabine
|
|
US5652216A
(en)
|
1994-05-26 |
1997-07-29 |
Novo Nordisk A/S |
Pharmaceutical preparation
|
|
CA2197671A1
(en)
|
1994-06-15 |
1995-12-21 |
Hubert Menendez |
Locking device for syringe or like instrument
|
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
|
US5827232A
(en)
|
1994-06-22 |
1998-10-27 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
|
US5725508A
(en)
|
1994-06-22 |
1998-03-10 |
Becton Dickinson And Company |
Quick connect medication delivery pen
|
|
US5440976A
(en)
|
1994-08-23 |
1995-08-15 |
Fred Giuliano |
Adjustable dispensing stirrer for soluble sweeteners
|
|
AU3264595A
(en)
|
1994-08-24 |
1996-03-14 |
Eli Lilly Japan Kabushiki Kaisha |
Injection apparatus
|
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
|
US5549574A
(en)
|
1994-08-30 |
1996-08-27 |
Eli Lilly And Company |
Cartridge assembly for use in a pen-type medicament injector
|
|
CA2157219C
(en)
|
1994-08-31 |
2010-10-05 |
Munehiro Noda |
Process for purifying recombinant human serum albumin
|
|
JPH10505688A
(ja)
|
1994-09-09 |
1998-06-02 |
ノボ ノルディスク アクティーゼルスカブ |
コンタクトレンズの洗浄、消毒及び保存
|
|
US5549575A
(en)
|
1994-09-13 |
1996-08-27 |
Becton Dickinson And Company |
Cartridge retainer assembly for medication delivery pen
|
|
US5582598A
(en)
|
1994-09-19 |
1996-12-10 |
Becton Dickinson And Company |
Medication delivery pen with variable increment dose scale
|
|
DK0782393T3
(da)
|
1994-09-20 |
1998-09-07 |
Slagteriselskabet Danish Crown |
Fremgangsmåde til behandling ag en vandig proteinopløsning for at dræbe mikroorganismer deri uden atbevirke koagulering
|
|
ZA958073B
(en)
|
1994-09-28 |
1996-04-23 |
Anthony William Manicom |
Method of and apparatus for administering a drug to a patient
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
AU4298596A
(en)
|
1994-12-23 |
1996-07-19 |
Novo Nordisk A/S |
Protracted glp-1 compositions
|
|
DK2199378T3
(da)
|
1995-02-03 |
2012-10-29 |
Novozymes As |
alfa-amylase mutanter
|
|
JP2000510813A
(ja)
|
1995-02-06 |
2000-08-22 |
ジェネテイックス・インスティテュート・インコーポレイテッド |
Ｉｌ−１２用処方
|
|
GB9503969D0
(en)
|
1995-02-28 |
1995-04-19 |
Sams Bernard |
Incrementing mechanism
|
|
NZ302558A
(en)
|
1995-03-07 |
1999-11-29 |
Lilly Co Eli |
Dispensing apparatus with a medication cartridge with a manually adjustable metering mechanism
|
|
EP0871665B1
(en)
|
1995-03-17 |
2003-07-23 |
Novo Nordisk A/S |
Insulin derivatives
|
|
US5869602A
(en)
|
1995-03-17 |
1999-02-09 |
Novo Nordisk A/S |
Peptide derivatives
|
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
|
US5834428A
(en)
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
EP0840628B1
(en)
|
1995-06-02 |
2002-05-08 |
Novo Nordisk A/S |
Automatic withdrawal of piston rod
|
|
DK0828753T3
(da)
|
1995-06-02 |
2003-06-30 |
Novozymes As |
A1/Fe-behandling af en proteinopløsning efterfulgt af membranopkoncentrering
|
|
US5631347A
(en)
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
|
AU6188096A
(en)
|
1995-06-13 |
1997-01-09 |
Novo Nordisk A/S |
4-substituted-phenyl-boronic acids as enzyme stabilizers
|
|
US5674204A
(en)
|
1995-09-19 |
1997-10-07 |
Becton Dickinson And Company |
Medication delivery pen cap actuated dose delivery clutch
|
|
US5688251A
(en)
|
1995-09-19 |
1997-11-18 |
Becton Dickinson And Company |
Cartridge loading and priming mechanism for a pen injector
|
|
JP3060287B2
(ja)
|
1995-10-09 |
2000-07-10 |
参天製薬株式会社 |
アパファントを主薬とする水性点眼剤
|
|
US5899879A
(en)
|
1995-12-19 |
1999-05-04 |
Genesis Medical Technologies, Inc. |
Spring-actuated needleless injector
|
|
DE69722255T2
(de)
|
1996-02-23 |
2004-03-18 |
Novo Nordisk A/S |
Spritze mit elektronischer parameterdarstellung
|
|
EP0885014B1
(en)
|
1996-03-05 |
2002-10-23 |
Robert Gurny |
Pharmaceutical compositions containing buffered ortho ester polymers
|
|
DE69735089T2
(de)
|
1996-03-12 |
2006-08-31 |
Novo Nordisk A/S |
Injektionsvorrichtung mit elektronischer anzeige von eingestellten dosierungen
|
|
ATE221396T1
(de)
|
1996-04-02 |
2002-08-15 |
Disetronic Licensing Ag |
Injektionsgerät
|
|
RU2180861C2
(ru)
|
1996-04-24 |
2002-03-27 |
Ново Нордиск А/С |
Инъекционная игла
|
|
DE122010000020I1
(de)
|
1996-04-25 |
2010-07-08 |
Prosidion Ltd |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
|
SK284490B6
(sk)
|
1996-07-03 |
2005-05-05 |
Alza Corporation |
Stabilná nevodná formulácia a spôsob jej prípravy
|
|
EP0910419B1
(en)
|
1996-07-05 |
2004-05-26 |
Novo Nordisk A/S |
Dose setting device
|
|
EP0910418B1
(en)
|
1996-07-05 |
2003-09-10 |
Novo Nordisk A/S |
Automatic needle insertion mechanism
|
|
HUP9904152A3
(en)
|
1996-07-05 |
2000-05-29 |
Novo Nordisk As |
Flexible piston rod
|
|
US5981489A
(en)
|
1996-07-18 |
1999-11-09 |
Alza Corporation |
Non-aqueous protic peptide formulations
|
|
US5962407A
(en)
|
1996-07-26 |
1999-10-05 |
Kelly; Michael T. |
Loloatin derivatives and analogs
|
|
ES2359031T3
(es)
|
1996-08-08 |
2011-05-17 |
Amylin Pharmaceuticals, Inc. |
Composición farmacéutica que comprende un péptido de exendina-4.
|
|
JPH10101696A
(ja)
|
1996-08-08 |
1998-04-21 |
Shinotesuto:Kk |
形質転換体にて発現される蛋白質に含まれる夾雑物質の除去方法及び精製蛋白質
|
|
US5709662A
(en)
|
1996-08-23 |
1998-01-20 |
Becton Dickinson France, S.A. |
Cartridge for an injection device
|
|
US5843036A
(en)
|
1996-08-23 |
1998-12-01 |
Becton Dickinson And Company |
Non-dosing cartridge for an injection device
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6277819B1
(en)
|
1996-08-30 |
2001-08-21 |
Eli Lilly And Company |
Use of GLP-1 or analogs in treatment of myocardial infarction
|
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
PT944648E
(pt)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk As |
Derivados do glp-1.
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US5947934A
(en)
|
1996-09-13 |
1999-09-07 |
Novo Nordisk A/S |
Dose display for an injection syringe
|
|
US6379339B1
(en)
|
1996-09-13 |
2002-04-30 |
Nova Nordisk A/S |
Syringe
|
|
UA49912C2
(uk)
|
1996-09-13 |
2002-10-15 |
Ново Нордіск А/С |
Шприц для ін'єкцій
|
|
US6110149A
(en)
|
1996-09-13 |
2000-08-29 |
Novo Nordisk A/S |
Syringe
|
|
DE69708894T2
(de)
|
1996-09-20 |
2002-08-22 |
Novo Nordisk A/S, Bagsvaerd |
Arbeitszylinder
|
|
US6146361A
(en)
|
1996-09-26 |
2000-11-14 |
Becton Dickinson And Company |
Medication delivery pen having a 31 gauge needle
|
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
TW524667B
(en)
|
1996-12-05 |
2003-03-21 |
Pfizer |
Parasiticidal pyrazoles
|
|
US5954689A
(en)
|
1996-12-20 |
1999-09-21 |
Novo Nordisk A/S |
Jet injector
|
|
ATE304864T1
(de)
|
1997-01-07 |
2005-10-15 |
Amylin Pharmaceuticals Inc |
Verwendung von exedinen und deren antagonisten zur verminderung der lebensmittelaufnahme
|
|
US6136784A
(en)
|
1997-01-08 |
2000-10-24 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
|
US7312196B2
(en)
|
1997-01-08 |
2007-12-25 |
Amylin Pharmaceuticals, Inc. |
Formulations for amylin agonist peptides
|
|
TW503113B
(en)
|
1997-01-16 |
2002-09-21 |
Senju Pharma Co |
Aqueous suspension for nasal administration
|
|
KR20000070338A
(ko)
|
1997-01-20 |
2000-11-25 |
나가시마 카쭈시게, 노미야마 아키히코 |
펩티드의 안정화 방법 및 당해 방법을 이용한 펩티드 함유 동결건조 의약조성물
|
|
GB2321419B
(en)
|
1997-01-27 |
2001-02-07 |
Medic Aid Ltd |
Atomizer
|
|
EP0971760A1
(en)
|
1997-02-04 |
2000-01-19 |
Novo Nordisk A/S |
A device for the administration of a liquid medicament suspension
|
|
DE29703820U1
(de)
|
1997-03-03 |
1998-07-02 |
Medico Development Investment Co., Ascona |
Injektionsgerät
|
|
US5898028A
(en)
|
1997-03-20 |
1999-04-27 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
|
US6277097B1
(en)
|
1997-03-25 |
2001-08-21 |
Novo Nordisk A/S |
Injection system
|
|
WO1998043658A1
(en)
|
1997-03-31 |
1998-10-08 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
|
CA2236519C
(en)
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methods of enhancing functioning of the large intestine
|
|
US7101853B2
(en)
|
1997-05-06 |
2006-09-05 |
Amylin Pharmaceuticals, Inc. |
Method for treating or preventing gastritis using amylin or amylin agonists
|
|
RU2111019C1
(ru)
|
1997-05-22 |
1998-05-20 |
Сергей Александрович Хворостов |
Универсальный инъектор
|
|
NZ501323A
(en)
|
1997-05-23 |
2001-04-27 |
Predrag Sikiric |
BPC (Body Protection Compound) peptide salts with organo-protective activity and their use in disorders associated with somatosensory neuron dysfunction
|
|
US7910548B2
(en)
|
1997-06-06 |
2011-03-22 |
Amylin Pharmaceuticals, Inc. |
Methods for treating obesity
|
|
US6074372A
(en)
|
1997-06-09 |
2000-06-13 |
Novo Nordisk A/S |
Dose setting mechanism and an injection syringe having such a dose setting mechanism
|
|
EP1014979A4
(en)
|
1997-06-09 |
2003-08-20 |
Bridge Pharma Inc |
CONNECTIONS WITH COMBINED ANTIHISTAMINIC AND FAST-CELL STABILIZING ACTIVITY FOR OPHTHALMOLOGICAL USE
|
|
US6003736A
(en)
|
1997-06-09 |
1999-12-21 |
Novo Nordisk A/S |
Device for controlled dispensing of a dose of a liquid contained in a cartridge
|
|
CO4750643A1
(es)
|
1997-06-13 |
1999-03-31 |
Lilly Co Eli |
Formulacion estable de la insulina que contiene l-arginina y protamina
|
|
US6796970B1
(en)
|
1997-06-17 |
2004-09-28 |
Novo Nordisk A/S |
Dose setting device
|
|
US5961496A
(en)
|
1997-06-17 |
1999-10-05 |
Novo Nordisk A/S |
Syringe with tiltable nut for quick piston disengagement
|
|
JP3503129B2
(ja)
|
1997-06-30 |
2004-03-02 |
荒川化学工業株式会社 |
カラーフィルタ層用剥離剤およびカラーフィルタ用ガラス基板の再生方法
|
|
EP1015050A1
(en)
|
1997-07-11 |
2000-07-05 |
Novo Nordisk A/S |
An apparatus for the registration of the setting of a medical device
|
|
AU8333398A
(en)
|
1997-07-14 |
1999-02-10 |
Novo Nordisk A/S |
Injection member
|
|
ATE240755T1
(de)
|
1997-07-14 |
2003-06-15 |
Novo Nordisk As |
Zylindrische ampulle
|
|
DE19730999C1
(de)
|
1997-07-18 |
1998-12-10 |
Disetronic Licensing Ag |
Dosierknopfsicherung an einer Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
|
|
US5921966A
(en)
|
1997-08-11 |
1999-07-13 |
Becton Dickinson And Company |
Medication delivery pen having an improved clutch assembly
|
|
FR2767479B1
(fr)
|
1997-08-22 |
1999-10-22 |
Aguettant Lab |
Dispositif d'injection de medicament
|
|
AU9202398A
(en)
|
1997-09-29 |
1999-04-23 |
Becton Dickinson & Company |
Injection device and drug cartridge for preventing cross-use of the device and drug cartridge
|
|
EP1952802A3
(en)
|
1997-10-01 |
2009-06-17 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray or capsule
|
|
CA2306447C
(en)
|
1997-10-24 |
2009-04-07 |
Genentech, Inc. |
Purification of molecules
|
|
EP1025125B1
(en)
|
1997-10-24 |
2003-06-25 |
Novo Nordisk A/S |
Aggregates of human insulin derivatives
|
|
US6312413B1
(en)
|
1997-10-30 |
2001-11-06 |
Novo Nordisk A/S |
Cylinder ampoule
|
|
EP1049486A4
(en)
|
1997-12-05 |
2006-01-04 |
Lilly Co Eli |
GLP-1 FORMULATIONS
|
|
ZA9811127B
(en)
|
1997-12-09 |
2000-07-11 |
Lilly Co Eli |
Stabilized teriparatide solutions.
|
|
DE29721752U1
(de)
|
1997-12-09 |
1998-02-12 |
Siemens AG, 80333 München |
Crimpkontakt für Stecksysteme
|
|
US6380357B2
(en)
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
|
JPH11249087A
(ja)
|
1997-12-18 |
1999-09-17 |
Tome:Kk |
コンタクトレンズ用液剤
|
|
WO1999034764A2
(en)
|
1998-01-09 |
1999-07-15 |
Amylin Pharmaceuticals, Inc. |
Amylin agonist pharmaceutical compositions containing insulin
|
|
DK1044015T3
(da)
|
1998-01-09 |
2008-12-08 |
Amylin Pharmaceuticals Inc |
Formuleringer med amylinagonistpeptider og insulin
|
|
DK0978565T3
(da)
|
1998-01-30 |
2008-02-04 |
Asubio Pharma Co Ltd |
Fremgangsmåde til fremstilling af peptid under anvendelse af et hjælperpeptid
|
|
CA2305634C
(en)
|
1998-01-30 |
2006-01-03 |
Novo Nordisk A/S |
An injection syringe
|
|
AU741072B2
(en)
|
1998-02-13 |
2001-11-22 |
Vetoquinol Usa, Inc. |
Drug delivery system
|
|
ATE491723T1
(de)
|
1998-02-13 |
2011-01-15 |
Amylin Pharmaceuticals Inc |
Neue verbindungen mit gemischter amylin aktivität
|
|
DE69936446T2
(de)
|
1998-02-13 |
2008-03-06 |
Amylin Pharmaceuticals, Inc., San Diego |
Inotropische und diuretische effekte von exendin und glp-1
|
|
US6221053B1
(en)
|
1998-02-20 |
2001-04-24 |
Becton, Dickinson And Company |
Multi-featured medication delivery pen
|
|
US6096010A
(en)
|
1998-02-20 |
2000-08-01 |
Becton, Dickinson And Company |
Repeat-dose medication delivery pen
|
|
US6248095B1
(en)
|
1998-02-23 |
2001-06-19 |
Becton, Dickinson And Company |
Low-cost medication delivery pen
|
|
AU2610799A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Glp-1 derivatives with helix-content exceeding 25 per cent, forming partially structured micellar-like aggregates
|
|
JP2003522099A
(ja)
|
1998-02-27 |
2003-07-22 |
ノボ ノルディスク アクティーゼルスカブ |
遅延作用プロファイルを有するｇｌｐ−１のｇｌｐ−１誘導体及びエキセンジン
|
|
JP2002508162A
(ja)
|
1998-02-27 |
2002-03-19 |
ノボ ノルディスク アクティーゼルスカブ |
Ｎ末端を短縮したｇｌｐ−１誘導体
|
|
DE69942306D1
(de)
|
1998-02-27 |
2010-06-10 |
Novo Nordisk As |
Abkömmlinge von glp-1 analogen
|
|
AU2610899A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
|
AU2612599A
(en)
|
1998-03-13 |
1999-10-11 |
Novo Nordisk A/S |
Stabilized aqueous peptide solutions
|
|
ATE269103T1
(de)
|
1998-03-13 |
2004-07-15 |
Novo Nordisk As |
Stabilisierte wässerige glukagonlösungen enthaltend detergenzien
|
|
US6245572B1
(en)
|
1998-05-01 |
2001-06-12 |
University Of Tennessee Research Corporation |
Flow cytometric characterization of amyloid fibrils
|
|
JP2002517435A
(ja)
|
1998-06-11 |
2002-06-18 |
シーラス コーポレイション |
動脈平滑筋細胞の増殖阻害のためのアルキル化化合物の使用
|
|
EP1094857B1
(en)
|
1998-07-08 |
2003-10-08 |
Novo Nordisk A/S |
A medical delivery device and a cartridge assembly for use in the same
|
|
US6440930B1
(en)
|
1998-09-17 |
2002-08-27 |
Eli Lilly And Company |
Protein formulations
|
|
US6033376A
(en)
|
1998-09-30 |
2000-03-07 |
Allergan Sales, Inc. |
Wound shaper sleeve
|
|
US6489292B1
(en)
|
1998-11-18 |
2002-12-03 |
Novo Nordisk A/S |
Stable aqueous insulin preparations without phenol and cresol
|
|
US6605067B1
(en)
|
1998-11-20 |
2003-08-12 |
Novo Nordisk A/S |
Injection needle
|
|
US6375975B1
(en)
|
1998-12-21 |
2002-04-23 |
Generex Pharmaceuticals Incorporated |
Pharmaceutical compositions for buccal and pulmonary application
|
|
ES2249933T3
(es)
|
1998-12-22 |
2006-04-01 |
Eli Lilly And Company |
Formulacion autoestable de peptido 1 tipo glucagon.
|
|
DE29900482U1
(de)
|
1999-01-14 |
2000-08-31 |
Medico Development Investment Co., Ascona |
Injektionsgerät
|
|
DE122007000001I1
(de)
|
1999-01-14 |
2007-06-28 |
Amylin Pharmaceuticals Inc |
Neue exendin agonist Formulierungen und deren Verabreichung
|
|
WO2000047332A1
(de)
|
1999-02-14 |
2000-08-17 |
Ing. Erich Pfeiffer Gmbh |
Spender für fliessfähige medien
|
|
US6258062B1
(en)
|
1999-02-25 |
2001-07-10 |
Joseph M. Thielen |
Enclosed container power supply for a needleless injector
|
|
US6444788B1
(en)
|
1999-03-15 |
2002-09-03 |
Novo Nordisk A/S |
Ion exchange chromatography of GLP-1, analogs and derivatives thereof
|
|
CZ20013018A3
(cs)
|
1999-03-17 |
2002-02-13 |
Novo Nordisk A/S |
Způsob pro acylování aminoskupiny peptidu nebo proteinu a sloučenina
|
|
SE9901366D0
(sv)
|
1999-04-16 |
1999-04-16 |
Pharmacia & Upjohn Ab |
Injector device and method for its operation
|
|
FR2793684B1
(fr)
|
1999-05-17 |
2001-08-10 |
Ethypharm Lab Prod Ethiques |
Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
|
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
|
EP1207753A4
(en)
|
1999-06-17 |
2005-11-30 |
Univ California |
PRESERVATION OF ORGANS BY CONTINUOUS CARDIAC PERFUSION WITH PEG-HB FOR IMPROVED PRESERVATION IN HYPOTHERMIA
|
|
US6660716B1
(en)
|
1999-06-21 |
2003-12-09 |
Eli Lilly And Company |
Method for treating non-insulin dependent diabetes using thiazolidinediones with glucagon-like peptide-1 and agonists thereof
|
|
CA2369839A1
(en)
|
1999-06-25 |
2001-01-04 |
Minimed, Inc. |
Compositions of insulin and insulin-related peptide for treating diabetes
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
|
AU6892100A
(en)
|
1999-08-05 |
2001-03-05 |
Becton Dickinson & Company |
Medication delivery pen
|
|
TW453884B
(en)
|
1999-09-16 |
2001-09-11 |
Novo Nordisk As |
Dose setting limiter
|
|
CA2383574A1
(en)
|
1999-09-20 |
2001-03-29 |
Eli Lilly And Company |
Method for reducing the risk of cancer
|
|
US6514230B1
(en)
|
1999-10-12 |
2003-02-04 |
Novo Nordisk A/S |
Air shot mechanism for electronic injection devices
|
|
US6569832B1
(en)
|
1999-11-12 |
2003-05-27 |
Novo Nordisk A/S |
Inhibition of beta cell degeneration
|
|
AU777570B2
(en)
|
1999-12-16 |
2004-10-21 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
|
GB9930882D0
(en)
|
1999-12-30 |
2000-02-23 |
Nps Allelix Corp |
GLP-2 formulations
|
|
EP1250126A2
(en)
|
2000-01-11 |
2002-10-23 |
Novo Nordisk A/S |
Transepithelial delivery of glp-1 derivatives
|
|
AU2001220765A1
(en)
|
2000-01-24 |
2001-07-31 |
Medtronic Minimed, Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
|
US7598222B2
(en)
|
2000-01-27 |
2009-10-06 |
Eli Lilly And Company |
Process for solubilizing glucagon-like peptide 1 compounds
|
|
EP1396499A3
(en)
|
2000-01-27 |
2004-12-29 |
Eli Lilly And Company |
Process for solubilizing glucagon-like peptide 1 (GLP-1) compounds
|
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
|
GB0007071D0
(en)
|
2000-03-24 |
2000-05-17 |
Sams Bernard |
One-way clutch mechanisms and injector devices
|
|
WO2001077141A1
(en)
|
2000-04-06 |
2001-10-18 |
Novo Nordisk A/S |
Shock heat treatment of polypeptides
|
|
US6692472B2
(en)
|
2000-05-04 |
2004-02-17 |
Novo Nordisk A/S |
Injection device, a preassembled dose setting and injection mechanism for an injection device, and a method of assembling an injection device
|
|
CA2380423A1
(en)
|
2000-05-17 |
2001-11-22 |
Bionebraska, Inc. |
Peptide pharmaceutical formulations
|
|
US6716198B2
(en)
|
2000-05-18 |
2004-04-06 |
Novo Nordisk A/S |
Injection device
|
|
US6547763B2
(en)
|
2000-05-18 |
2003-04-15 |
Novo Nordisk A/S |
Dose display for injection device
|
|
US6547764B2
(en)
|
2000-05-31 |
2003-04-15 |
Novo Nordisk A/S |
Double pointed injection needle
|
|
PL206302B1
(pl)
|
2000-06-16 |
2010-07-30 |
Elli Lilly And Companyelli Lilly And Company |
Związek GLP-1
|
|
US6663602B2
(en)
|
2000-06-16 |
2003-12-16 |
Novo Nordisk A/S |
Injection device
|
|
US6369419B1
(en)
|
2000-06-23 |
2002-04-09 |
International Business Machines Corporation |
Self-aligned near surface strap for high density trench DRAMS
|
|
DE60132926T2
(de)
|
2000-07-14 |
2009-02-19 |
Novo Nordisk A/S |
Flüssigkeitsabgabevorrichtung und verfahren zum vermindern des tröpfelns
|
|
WO2002024257A1
(en)
|
2000-09-22 |
2002-03-28 |
Novo Nordisk A/S |
A medication delivery device
|
|
JP4798833B2
(ja)
|
2000-10-24 |
2011-10-19 |
一般財団法人化学及血清療法研究所 |
加熱処理工程を含むヒト血清アルブミンの製造方法
|
|
US7271149B2
(en)
|
2000-12-07 |
2007-09-18 |
Eli Lilly And Company |
GLP-1 fusion proteins
|
|
EP1351984A2
(en)
|
2000-12-13 |
2003-10-15 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
|
AU3938402A
(en)
|
2000-12-13 |
2002-06-24 |
Lilly Co Eli |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
|
US20020151467A1
(en)
|
2000-12-21 |
2002-10-17 |
Leung Frank K. |
Methods and compositions for oral insulin delivery
|
|
US6899699B2
(en)
|
2001-01-05 |
2005-05-31 |
Novo Nordisk A/S |
Automatic injection device with reset feature
|
|
GB2371227A
(en)
|
2001-01-10 |
2002-07-24 |
Grandis Biotech Gmbh |
Crystallisation - resistant aqueous growth hormone formulations
|
|
WO2002064196A1
(en)
|
2001-02-14 |
2002-08-22 |
Novo Nordisk A/S |
Electronically controlled injection or infusion device
|
|
AU2002233089B2
(en)
|
2001-02-16 |
2005-12-22 |
Conjuchem Biotechnologies Inc. |
Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
|
|
EP1949908A1
(en)
|
2001-03-07 |
2008-07-30 |
Novo Nordisk A/S |
Combined use of derivatives of GLP-1 analogs and PPAR ligands
|
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
|
ES2400055T3
(es)
|
2001-05-16 |
2013-04-05 |
Eli Lilly And Company |
Aparato inyector de medicamentos
|
|
US20040156835A1
(en)
|
2001-05-30 |
2004-08-12 |
Taiji Imoto |
Protein preparation
|
|
GB0113881D0
(en)
|
2001-06-07 |
2001-08-01 |
Innovate Biomed Ltd |
Foil cutting system
|
|
ES2298378T3
(es)
|
2001-06-28 |
2008-05-16 |
Novo Nordisk A/S |
Formulacion estable de glp-1 modificado.
|
|
US6872705B2
(en)
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
|
DE10163326A1
(de)
|
2001-07-30 |
2003-02-27 |
Disetronic Licensing Ag |
Verabreichungsgerät mit Dosiervorrichtung
|
|
CN1335182A
(zh)
|
2001-08-08 |
2002-02-13 |
华中科技大学 |
胰岛素口腔喷剂及其制备工艺
|
|
CN1635900A
(zh)
|
2001-08-28 |
2005-07-06 |
伊莱利利公司 |
Glp－1和基础胰岛素的预混合物
|
|
US6676641B2
(en)
|
2001-09-05 |
2004-01-13 |
Futura Medical Technologies, Inc. |
Retractable hypodermic syringe
|
|
EP1572892A4
(en)
|
2001-10-18 |
2007-08-22 |
Bristol Myers Squibb Co |
HUMAN GLUCAGON-LIKE-PEPTIDE-1 MIMICS AND THEIR USE IN THE TREATMENT OF DIABETES AND RELATED CONDITIONS
|
|
JP2005508360A
(ja)
|
2001-10-19 |
2005-03-31 |
イーライ・リリー・アンド・カンパニー |
Ｇｌｐ−１およびインスリンの二相混合物
|
|
WO2003072195A2
(en)
|
2002-02-20 |
2003-09-04 |
Eli Lilly And Company |
Method for administering glp-1 molecules
|
|
US20030175355A1
(en)
|
2002-03-07 |
2003-09-18 |
Tobyn Michael John |
Fast melt multiparticulate formulations for oral delivery
|
|
ATE337014T1
(de)
|
2002-03-15 |
2006-09-15 |
Natimmune As |
Mannose-bindungsprotein enthaltende pharmazeutische zusammensetzungen
|
|
WO2003084563A1
(en)
|
2002-04-04 |
2003-10-16 |
Novo Nordisk A/S |
Glp-1 agonist and cardiovascular complications
|
|
JP2005535652A
(ja)
|
2002-07-09 |
2005-11-24 |
サンド・アクチエンゲゼルシヤフト |
１，２−プロピレングリコールを含有するヒト成長ホルモン（ｈＧＨ）の高濃度液体製剤
|
|
US6945961B2
(en)
|
2002-07-10 |
2005-09-20 |
Novo Nordisk A/S |
Injection device
|
|
AU2003239785A1
(en)
|
2002-07-10 |
2004-02-02 |
Novo Nordisk A/S |
An injection device with a dose setting limiter
|
|
EP1391794A1
(en)
|
2002-07-23 |
2004-02-25 |
Novo Nordisk A/S |
Device with time indicating means
|
|
WO2004020026A1
(en)
|
2002-08-29 |
2004-03-11 |
Novo Nordisk A/S |
Frontloaded injection device
|
|
US7112187B2
(en)
|
2002-09-24 |
2006-09-26 |
Shl Medical Ab |
Injecting device
|
|
US7273921B2
(en)
|
2002-09-25 |
2007-09-25 |
Novo Nordisk A/S |
Method for producing acylated peptides
|
|
AU2003266216A1
(en)
|
2002-09-25 |
2004-04-19 |
Novo Nordisk A/S |
Purification process comprising microfiltration at elevated temperatures
|
|
AU2003278929A1
(en)
|
2002-10-18 |
2004-05-13 |
Amylin Pharmaceuticals, Inc. |
Treatment of pancreatitis with amylin
|
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
|
AU2003297356A1
(en)
|
2002-12-17 |
2004-07-14 |
Amylin Pharmaceuticals, Inc. |
Prevention and treatment of cardiac arrhythmias
|
|
WO2004066939A2
(en)
|
2003-01-27 |
2004-08-12 |
Sarnoff Corporation |
Controlled-release drug delivery system
|
|
GB0304822D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
|
GB0304824D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
|
GB0304823D0
(en)
|
2003-03-03 |
2003-04-09 |
Dca Internat Ltd |
Improvements in and relating to a pen-type injector
|
|
GB0306642D0
(en)
|
2003-03-22 |
2003-04-30 |
Dca Design Int Ltd |
Improvements in and relating to an injector for a medical product
|
|
GB0308267D0
(en)
|
2003-04-10 |
2003-05-14 |
Dca Design Int Ltd |
Improvements in and relating to a pen-type injector
|
|
WO2004089985A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Stable pharmaceutical compositions
|
|
EP1631308B1
(en)
|
2003-05-30 |
2013-07-31 |
Amylin Pharmaceuticals, LLC |
Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
|
BRPI0410972C1
(pt)
*
|
2003-06-03 |
2021-05-25 |
Novo Nordisk As |
método para aumentar a vida de armazenagem de uma composição farmacêutica, composição farmacêutica, e, método para tratamento de hiperglicemia
|
|
MXPA05013048A
(es)
|
2003-06-03 |
2006-03-02 |
Novo Nordisk As |
Composiciones peptodicas farmaceuticas estabilizadas.
|
|
CN1812807A
(zh)
*
|
2003-06-03 |
2006-08-02 |
诺沃挪第克公司 |
稳定化的药物肽组合物
|
|
KR101121317B1
(ko)
|
2003-08-12 |
2012-03-09 |
일라이 릴리 앤드 캄파니 |
기계적 확대율을 갖는 삼중 나사식 쓰레드를 갖는 약제투여 장치
|
|
WO2005021026A2
(en)
|
2003-08-29 |
2005-03-10 |
Amylin Pharmaceuticals, Inc. |
Methods for treating or ameliorating ghrelin-associated diseases and disorders
|
|
BRPI0414539B8
(pt)
|
2003-09-19 |
2021-05-25 |
Novo Nordisk As |
composto, composição farmacêutica, e, uso de um composto
|
|
TW200523252A
(en)
|
2003-10-31 |
2005-07-16 |
Takeda Pharmaceutical |
Pyridine compounds
|
|
ZA200604419B
(en)
|
2003-11-04 |
2008-06-25 |
Novartis Vaccines & Diagnostic |
Antagonist anti-CD40 monoclonal antibodies and methods for their use
|
|
KR101438983B1
(ko)
|
2003-11-06 |
2014-09-05 |
시애틀 지네틱스, 인크. |
리간드에 접합될 수 있는 모노메틸발린 화합물
|
|
US20060287221A1
(en)
|
2003-11-13 |
2006-12-21 |
Novo Nordisk A/S |
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
|
|
WO2005046716A1
(en)
|
2003-11-13 |
2005-05-26 |
Novo Nordisk A/S |
Soluble pharmaceutical compositions for parenteral administration comprising a glp-1 peptide and a insulin peptide of short time action for treatment of diabetes and bulimia
|
|
MXPA06005581A
(es)
|
2003-11-20 |
2006-08-11 |
Novo Nordisk As |
Formulaciones de peptidos que contienen propilenglicol que son optimas para la produccion y uso en dispositivos de inyeccion.
|
|
TWI353250B
(en)
|
2003-12-16 |
2011-12-01 |
Ipsen Pharma Sas |
Glp-1 pharmaceutical compositions
|
|
US20060286129A1
(en)
|
2003-12-19 |
2006-12-21 |
Emisphere Technologies, Inc. |
Oral GLP-1 formulations
|
|
US20050143303A1
(en)
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
|
DE602005021858D1
(de)
|
2004-02-11 |
2010-07-29 |
Amylin Pharmaceuticals Inc |
Peptide der amylin familie, verfahren zu deren herstellung und verwendung
|
|
EP1765406A4
(en)
|
2004-05-21 |
2012-11-28 |
Mediplex Corp |
ADDITIVES FOR IMPROVED MUCOSAL ABSORPTION OF THERAPEUTIC AGENTS
|
|
US7448385B2
(en)
|
2004-06-07 |
2008-11-11 |
Purepharm Inc. |
Nasal adaptation of an oral inhaler device
|
|
EP1758575A1
(en)
|
2004-06-11 |
2007-03-07 |
Novo Nordisk A/S |
Counteracting drug-induced obesity using glp-1 agonists
|
|
JP2008504249A
(ja)
|
2004-06-28 |
2008-02-14 |
ノボ ノルディスク アクティーゼルスカブ |
糖尿病を治療するための方法
|
|
EP1789075A4
(en)
|
2004-08-25 |
2009-07-01 |
Uab Research Foundation |
ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
|
|
EP1814590B2
(en)
|
2004-11-01 |
2013-12-11 |
Amylin Pharmaceuticals, Inc. |
Treatment of obesity and related disorders
|
|
JP5248113B2
(ja)
|
2004-11-12 |
2013-07-31 |
ノヴォ ノルディスク アー／エス |
ペプチドの安定な処方
|
|
CN112618700A
(zh)
|
2004-11-12 |
2021-04-09 |
诺和诺德公司 |
促胰岛素肽的稳定制剂
|
|
US7910577B2
(en)
|
2004-11-16 |
2011-03-22 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
|
JP4970282B2
(ja)
|
2005-01-21 |
2012-07-04 |
ノボ・ノルデイスク・エー／エス |
上部に解放機構を有する自動注入装置
|
|
AU2006220829C1
(en)
|
2005-03-08 |
2024-02-01 |
Pfizer Products Inc. |
Anti-CTLA-4 antibody compositions
|
|
US8834891B2
(en)
|
2005-03-14 |
2014-09-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Immunogenic compositions comprising Lawsonia intracellularis
|
|
TWI372629B
(en)
*
|
2005-03-18 |
2012-09-21 |
Novo Nordisk As |
Acylated glp-1 compounds
|
|
WO2007014051A2
(en)
|
2005-07-22 |
2007-02-01 |
Amylin Pharmaceuticals, Inc. |
Use of amylin and amylin agonists as cardioprotective or myoprotective agents
|
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
|
EP1978926A2
(en)
|
2005-12-19 |
2008-10-15 |
Comentis, Inc. |
Topical mecamylamine formulations for ocular administration and uses thereof
|
|
MX356667B
(es)
|
2005-12-29 |
2018-06-08 |
Boehringer Ingelheim Vetmedica Inc |
Uso de una composicion inmunogenica de pcv2 para reducir los sintomas clinicos en cerdos.
|
|
NZ571862A
(en)
|
2006-04-13 |
2011-10-28 |
Ipsen Pharma Sas |
Pharmaceutical composition comprising HGLP-1, a zinc divalent metal ion and a solvent
|
|
AU2007275294A1
(en)
|
2006-07-18 |
2008-01-24 |
Centocor, Inc. |
Human GLP-1 mimetibodies, compositions, methods and uses
|
|
TWI489984B
(zh)
|
2006-08-04 |
2015-07-01 |
Wyeth Corp |
用於非經腸道傳輸化合物之配方及其用途
|
|
TW200843794A
(en)
|
2006-12-21 |
2008-11-16 |
Centocor Inc |
Use of long-acting GLP-1 receptor agonists to improve insulin sensitivity and lipid profiles
|
|
GB0704846D0
(en)
|
2007-03-13 |
2007-04-18 |
Futura Medical Dev Ltd |
Topical pharmaceutical formulation
|
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
WO2009030771A1
(en)
|
2007-09-05 |
2009-03-12 |
Novo Nordisk A/S |
Peptides derivatized with a-b-c-d- and their therapeutical use
|
|
WO2009040019A2
(en)
|
2007-09-11 |
2009-04-02 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
WO2009051992A1
(en)
|
2007-10-19 |
2009-04-23 |
Bausch & Lomb Incorporated |
Compositions and methods for treating diseases involving ocular angiogenesis by inhibiting one or more selected receptor tyrosine kinases
|
|
KR20100098628A
(ko)
|
2007-11-14 |
2010-09-08 |
아밀린 파마슈티칼스, 인크. |
비만 및 비만 관련 질환 및 장애의 치료 방법
|
|
JP2011506442A
(ja)
|
2007-12-11 |
2011-03-03 |
コンジュケム バイオテクノロジーズ インコーポレイテッド |
インスリン分泌性ペプチド結合体の製剤
|
|
WO2010046357A1
(en)
|
2008-10-21 |
2010-04-29 |
Novo Nordisk A/S |
Amylin derivatives
|
|
WO2010107874A2
(en)
|
2009-03-17 |
2010-09-23 |
Amylin Pharmaceuticals, Inc. |
Methods for affecting body composition using amylin agonists
|
|
EP2437816B1
(en)
|
2009-06-04 |
2013-04-24 |
Novo Nordisk Health Care AG |
Mixing device with piston coupling arrangement
|
|
MA33466B1
(fr)
|
2009-07-31 |
2012-07-03 |
Sanofi Aventis Deutschland |
Composition d'insuline à longue duree d'action
|
|
AU2010277559B2
(en)
|
2009-07-31 |
2016-08-11 |
Sanofi-Aventis Deutschland Gmbh |
Prodrugs comprising an insulin linker conjugate
|
|
WO2011050008A2
(en)
|
2009-10-19 |
2011-04-28 |
Amylin Pharmaceuticals, Inc. |
Combination therapy comprising administration of an amylinomimetic and a pyy peptidomimetic for effecting weight loss and for treating obesity and related metabolic conditions and disorders
|
|
BR112012012862A2
(pt)
|
2009-12-10 |
2016-08-16 |
Merck Patent Gmbh |
composição farmacêutica compreendendo oligopeptídeos
|
|
CN102791731B
(zh)
|
2009-12-16 |
2016-04-20 |
诺沃—诺迪斯克有限公司 |
Glp-1类似物和衍生物
|
|
WO2011104378A1
(en)
|
2010-02-26 |
2011-09-01 |
Novo Nordisk A/S |
Peptides for treatment of obesity
|
|
WO2011109784A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Formulation of insulinotropic peptide conjugates
|
|
WO2011109787A1
(en)
|
2010-03-05 |
2011-09-09 |
Conjuchem, Llc |
Methods of administering insulinotropic peptides
|
|
CN102918056B
(zh)
|
2010-03-26 |
2016-08-10 |
诺沃—诺迪斯克有限公司 |
新的胰高血糖素类似物
|
|
CA2806749A1
(en)
|
2010-07-28 |
2012-02-02 |
Amylin Pharmaceuticals, Llc |
Glp-1 receptor agonist compounds having stabilized regions
|
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
|
ES2913803T3
(es)
|
2010-11-09 |
2022-06-06 |
Novo Nordisk As |
Derivados de GLP-1 diacilados
|
|
EP2665469A1
(en)
|
2011-01-19 |
2013-11-27 |
Novo Nordisk A/S |
Glp-1 compositions
|
|
AU2012213217B2
(en)
|
2011-02-04 |
2017-04-20 |
Infirst Healthcare Limited |
Compositions and methods for treating cardiovascular diseases
|
|
US20130035281A1
(en)
|
2011-02-09 |
2013-02-07 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
EP3225631B1
(en)
|
2011-04-12 |
2019-01-09 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives
|
|
UA116189C2
(uk)
|
2011-05-02 |
2018-02-26 |
Мілленніум Фармасьютікалз, Інк. |
КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
|
|
PL2718316T3
(pl)
|
2011-06-10 |
2020-06-29 |
Novo Nordisk A/S |
Polipeptydy
|
|
WO2013009539A1
(en)
|
2011-07-08 |
2013-01-17 |
Amylin Pharmaceuticals, Inc. |
Engineered polypeptides having enhanced duration of action and reduced immunogenicity
|
|
US9132170B2
(en)
|
2011-07-29 |
2015-09-15 |
Case Western Reserve University |
Compositions and methods for treating cognitive deficits
|
|
ES2626013T3
(es)
|
2011-09-06 |
2017-07-21 |
Novo Nordisk A/S |
Derivados de GLP-1
|
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對ｂｃｍａ之e3以及ｃｄ３的結合分子
|
|
EP2788027A2
(en)
|
2011-12-09 |
2014-10-15 |
Novo Nordisk A/S |
Glp-1 agonists
|
|
US9452225B2
(en)
|
2012-03-01 |
2016-09-27 |
Novo Nordisk A/S |
GLP-1 prodrugs
|
|
CN102579350B
(zh)
|
2012-03-02 |
2013-04-24 |
海南灵康制药有限公司 |
右旋布洛芬脂质体固体制剂
|
|
DE18200782T1
(de)
|
2012-04-02 |
2021-10-21 |
Modernatx, Inc. |
Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen
|
|
AU2013243920A1
(en)
|
2012-04-03 |
2014-10-09 |
Trustees Of Boston University |
Compositions, methods and assays comprising amylin or amlyin analogs for abeta-peptide mediated disorders
|
|
EP2838914B1
(en)
|
2012-04-19 |
2017-06-14 |
Novo Nordisk A/S |
Human amylin analogues
|
|
US11274135B2
(en)
|
2012-05-08 |
2022-03-15 |
Novo Nordisk A/S |
Double-acylated GLP-1 derivatives
|
|
EP2846823B1
(en)
|
2012-05-08 |
2019-12-04 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives
|
|
US20150174209A1
(en)
|
2012-05-25 |
2015-06-25 |
Amylin Pharmaceuticals. Llc |
Insulin-pramlintide compositions and methods for making and using them
|
|
ES2731474T3
(es)
|
2012-06-19 |
2019-11-15 |
Debiopharm Int Sa |
Derivados de profármaco de (E)-N-metil-N-((3-metilbenzofuran-2-il)metil)-3-(7-oxo-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)acrilamida
|
|
BR112014032938A2
(pt)
|
2012-07-01 |
2017-08-01 |
Novo Nordisk As |
uso de peptídeos de glp-1 de longa ação
|
|
EP2908844A1
(en)
*
|
2012-10-17 |
2015-08-26 |
Novo Nordisk A/S |
Fatty acid acylated amino acids for oral peptide delivery
|
|
CA3209602A1
(en)
|
2013-03-15 |
2014-09-18 |
Rhythm Pharmaceuticals, Inc. |
Pharmaceutical compositions
|
|
AU2014261336B2
(en)
|
2013-05-02 |
2019-02-28 |
Novo Nordisk A/S |
Oral dosing of GLP-1 compounds
|
|
US9765089B2
(en)
|
2013-05-10 |
2017-09-19 |
Gilead Apollo, Llc |
ACC inhibitors and uses thereof
|
|
CN105324126A
(zh)
|
2013-06-21 |
2016-02-10 |
诺和诺德股份有限公司 |
Glp-1受体激动剂在用胰岛素治疗的和/或患有1型糖尿病的患者中的新用途
|
|
JP6139712B2
(ja)
|
2013-07-04 |
2017-05-31 |
ノヴォ ノルディスク アー／エス |
Ｇｌｐ−１様ペプチドの誘導体及びその使用
|
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
|
CN103405753B
(zh)
|
2013-08-13 |
2016-05-11 |
上海仁会生物制药股份有限公司 |
稳定的促胰岛素分泌肽水针药物组合物
|
|
ES2741507T3
(es)
|
2014-04-07 |
2020-02-11 |
Novo Nordisk As |
Compuestos de glp-1 acilados doblemente
|
|
AU2015280110A1
(en)
|
2014-06-25 |
2017-01-12 |
Glaxosmithkline Llc |
Pharmaceutical compositions
|
|
WO2016001862A1
(en)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Extended release formulations of insulins
|
|
WO2016038521A1
(en)
|
2014-09-08 |
2016-03-17 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical compositions of liraglutide
|
|
ES2739289T3
(es)
*
|
2014-11-27 |
2020-01-30 |
Novo Nordisk As |
Derivados de GLP-1 y sus usos
|
|
CN105777872B
(zh)
*
|
2014-12-16 |
2019-06-07 |
深圳翰宇药业股份有限公司 |
一种萨摩鲁肽的纯化方法
|
|
US20190060410A1
(en)
|
2015-05-13 |
2019-02-28 |
Xiaoni LIU |
Pharmaceutical Formulation Comprising GLP-1 Analogue and Preparation Method Thereof
|
|
AR105284A1
(es)
|
2015-07-10 |
2017-09-20 |
Sanofi Sa |
Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
|
|
WO2017149070A1
(en)
|
2016-03-03 |
2017-09-08 |
Novo Nordisk A/S |
Glp-1 derivatives and uses thereof
|
|
RU2768283C2
(ru)
|
2016-04-28 |
2022-03-23 |
Ново Нордиск А/С |
Семаглутид при сердечно-сосудистых состояниях
|
|
US20190374613A1
(en)
|
2016-11-22 |
2019-12-12 |
Biocon Research Limited |
Pharmaceutical compositions of glp-1 analogues
|
|
GB201621987D0
(en)
|
2016-12-22 |
2017-02-08 |
Archer Virgil L See Archer Sheri A Arecor Ltd |
Novel composition
|
|
WO2018139991A1
(en)
|
2017-01-24 |
2018-08-02 |
Macregen, Inc. |
Treatment of age-related degeneration and other eye diseases with apolipoprotein mimetics
|
|
RS65380B1
(sr)
|
2017-08-24 |
2024-04-30 |
Novo Nordisk As |
Glp-1 kompozicije i njihova upotreba
|
|
EP3727332A1
(en)
|
2017-12-21 |
2020-10-28 |
Sanofi |
Liquid pharmaceutical composition
|
|
TWI705820B
(zh)
|
2018-06-22 |
2020-10-01 |
美商美國禮來大藥廠 |
Gip/glp1促效劑組合物
|
|
WO2020004368A1
(ja)
|
2018-06-25 |
2020-01-02 |
Ｊｃｒファーマ株式会社 |
蛋白質含有水性液剤
|
|
US20230093542A1
(en)
|
2020-02-18 |
2023-03-23 |
Novo Nordisk A/S |
Glp-1 compositions and uses thereof
|